Masaru Chiba-shi Taniguchi

Masaru Chiba-shi Taniguchi's AcademicInfluence.com Rankings

Biology

#7830

World Rank

#10808

Historical Rank

Immunology

#425

World Rank

#442

Historical Rank

biology Degrees

Download Badge

Biology

Masaru Chiba-shi Taniguchi's Degrees

PhD Immunology University of Tokyo
Doctorate Medicine University of Tokyo

Why Is Masaru Chiba-shi Taniguchi Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Masaru Chiba-shi Taniguchi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. (1997) (2301)
Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors (1997) (1302)
Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers (2000) (967)
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells (2000) (884)
Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity (2003) (745)
The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells (1999) (693)
The Regulatory Role of Vα14 NKT Cells in Innate and Acquired Immune Response (2003) (675)
Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes (2001) (668)
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells. (1998) (507)
Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. (1997) (455)
Augmentation of Vα14 Nkt Cell–Mediated Cytotoxicity by Interleukin 4 in an Autocrine Mechanism Resulting in the Development of Concanavalin a–Induced Hepatitis (2000) (434)
Selective Ability of Mouse CD1 to Present Glycolipids: α-Galactosylceramide Specifically Stimulates Vα14+ NK T Lymphocytes (1998) (411)
Disruption of the Bcl6 Gene Results in an Impaired Germinal Center Formation (1997) (391)
Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex (1976) (378)
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. (1999) (369)
A Phase I Study of α-Galactosylceramide (KRN7000)–Pulsed Dendritic Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer (2005) (364)
Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. (1996) (340)
Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria Vaccines (2002) (328)
Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis (1995) (318)
Requirement for natural killer T (NKT) cells in the induction of allograft tolerance (2001) (296)
Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. (1999) (291)
NKT cells are phenotypically and functionally diverse (1999) (279)
α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. (2000) (279)
NK T Cell-Derived IL-10 Is Essential for the Differentiation of Antigen-Specific T Regulatory Cells in Systemic Tolerance1 (2001) (275)
The regulatory role of Valpha14 NKT cells in innate and acquired immune response. (2003) (269)
The NKT cell system: bridging innate and acquired immunity (2003) (257)
Predominant expression of invariant Vα14+ TCR α chain in NK1.1+ T cell populations (1995) (256)
Antitumor Cytotoxicity Mediated by Ligand-activated Human Vα24 NKT Cells (1999) (248)
The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. (2000) (240)
A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity (2008) (239)
A Phase I Study of In vitro Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer (2006) (223)
A Novel Function of Vα14+CD4+NKT Cells: Stimulation of IL-12 Production by Antigen-Presenting Cells in the Innate Immune System (1999) (218)
Density-dependent recognition of cell surface GM3 by a certain anti-melanoma antibody, and GM3 lactone as a possible immunogen: requirements for tumor-associated antigen and immunogen. (1987) (211)
Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. (2004) (208)
Natural killer T cells accelerate atherogenesis in mice. (2003) (200)
Critical role of Vα14+ natural killer T cells in the innate phase of host protection against Streptococcus pneumoniae infection (2003) (200)
Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases. (2001) (200)
Identification of a Conserved GATA3 Response Element Upstream Proximal from the Interleukin-13 Gene Locus* 210 (2002) (196)
Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls (1999) (193)
Natural killer cells determine the outcome of B cell–mediated autoimmunity (2000) (191)
A Phase I-II Study of α-Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer1 (2009) (187)
Inhibition of T Helper Cell Type 2 Cell Differentiation and Immunoglobulin E Response by Ligand-Activated Vα14 Natural Killer T Cells (1999) (182)
Development and Function of Invariant Natural Killer T Cells Producing TH2- and TH17-Cytokines (2012) (182)
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses (2003) (178)
The transcription factor E4BP4 regulates the production of IL-10 and IL-13 in CD4+ T cells (2011) (176)
Monocyte Chemoattractant Protein-1-Dependent Increase of Vα14 NKT Cells in Lungs and Their Roles in Th1 Response and Host Defense in Cryptococcal Infection1 (2001) (168)
Essential Role of GATA3 for the Maintenance of Type 2 Helper T (Th2) Cytokine Production and Chromatin Remodeling at the Th2 Cytokine Gene Loci* (2004) (168)
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells (2007) (168)
Involvement of decidual Vα14 NKT cells in abortion (2000) (167)
Activation of Vα14+ Natural Killer T Cells by α-Galactosylceramide Results in Development of Th1 Response and Local Host Resistance in Mice Infected with Cryptococcus neoformans (2001) (167)
Combination therapy of in vitro‐expanded natural killer T cells and α‐galactosylceramide‐pulsed antigen‐presenting cells in patients with recurrent head and neck carcinoma (2009) (159)
alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. (2000) (158)
The Anti-Tumor Activity of IL-12: Mechanisms of Innate Immunity That Are Model and Dose Dependent1 (2000) (157)
Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation. (2004) (155)
Properties of antigen-specific suppressive T cell factor in the regulation of antibody response of the mouse. II. In vitro activity and evidence for the I region gene product. (1976) (154)
Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma. (1985) (153)
CD4(+) Valpha14 natural killer T cells are essential for acceptance of rat islet xenografts in mice. (2000) (152)
Regulatory dendritic cells act as regulators of acute lethal systemic inflammatory response. (2006) (151)
Generation of Cloned Mice by Direct Nuclear Transfer from Natural Killer T Cells (2005) (149)
Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer (2008) (143)
A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. (2005) (142)
Costimulation-Dependent Modulation of Experimental Autoimmune Encephalomyelitis by Ligand Stimulation of Vα14 NK T Cells1 (2001) (142)
CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. (2000) (136)
Enrichment of specific suppressor T cells and characterization of their surface markers (1977) (135)
Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy. (2011) (134)
Functionally distinct NKT cell subsets and subtypes (2005) (132)
Methods for detection, isolation and culture of mouse and human invariant NKT cells (2007) (132)
High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. (2010) (130)
CD8+ T Cells Rapidly Acquire NK1.1 and NK Cell-Associated Molecules Upon Stimulation In Vitro and In Vivo1 (2000) (130)
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. (1998) (129)
Regulation of homocytotropic antibody formation in the rat. II. Effect of X-irradiation. (1971) (128)
IL-18 Enhances IL-4 Production by Ligand-Activated NKT Lymphocytes: A Pro-Th2 Effect of IL-18 Exerted Through NKT Cells1 (2001) (127)
T Cell Receptor–Induced Calcineurin Activation Regulates T Helper Type 2 Cell Development by Modifying the Interleukin 4 Receptor Signaling Complex (2000) (125)
Antigen-specific suppressive factor produced by a transplantable I-J bearing T-cell hybridoma (1979) (125)
Properties of Primed Suppressor T Cells and their Products (1975) (125)
Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. (2005) (123)
Extrathymic development of V alpha 14-positive T cells (1993) (121)
IL-21–induced Bɛ cell apoptosis mediated by natural killer T cells suppresses IgE responses (2006) (121)
OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice. (2007) (120)
Essential requirement of an invariant V alpha 14 T cell antigen receptor expression in the development of natural killer T cells. (1996) (119)
Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. (1999) (119)
Tumor Cells Loaded with α-Galactosylceramide Induce Innate NKT and NK Cell-Dependent Resistance to Tumor Implantation in Mice1 (2007) (112)
src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation. (2003) (111)
Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. III. Dual gene control of the T-cell-mediated suppression of the antibody response (1976) (110)
NKT Cells as an Ideal Anti-Tumor Immunotherapeutic (2013) (108)
Agonist-selected T cell development requires strong T cell receptor signaling and store-operated calcium entry. (2013) (108)
Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line (1978) (106)
CD4(+)CD25(+) T-cell development is regulated by at least 2 distinct mechanisms. (2002) (105)
CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte–macrophage colony-stimulating factor-dependent fashion (2003) (103)
Immune Tolerance to Combined Organ and Bone Marrow Transplants After Fractionated Lymphoid Irradiation Involves Regulatory NK T Cells and Clonal Deletion1 (2002) (102)
Differential Role of Thymic Stromal Lymphopoietin in the Induction of Airway Hyperreactivity and Th2 Immune Response in Antigen-Induced Asthma with Respect to Natural Killer T Cell Function (2007) (100)
Vα14 NK T cell–triggered IFN-γ production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets (2005) (100)
Monoclonal anti-Ia murine alloantibodies crossreactive with the Ia-homologues of other mammalian species including humans. (1983) (98)
Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis. (2002) (97)
Regulation of homocytotropic antibody formation in the rat. IV. Effects of various immunosuppressive drugs. (1971) (96)
Mechanism of NKT cell activation by intranasal coadministration of α-galactosylceramide, which can induce cross-protection against influenza viruses (2008) (95)
Type II NKT Cells Stimulate Diet-Induced Obesity by Mediating Adipose Tissue Inflammation, Steatohepatitis and Insulin Resistance (2012) (94)
Progression of T cell lineage restriction in the earliest subpopulation of murine adult thymus visualized by the expression of lck proximal promoter activity. (2001) (94)
CD8 T cell-specific downregulation of histone hyperacetylation and gene activation of the IL-4 gene locus by ROG, repressor of GATA. (2003) (92)
Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis. (2008) (91)
During Trypanosoma cruzi Infection CD1d-Restricted NK T Cells Limit Parasitemia and Augment the Antibody Response to a Glycophosphoinositol-Modified Surface Protein (2002) (90)
Preserved IFN‐α production of circulating Vα24 NKT cells in primary lung cancer patients (2002) (90)
Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus. (1999) (90)
Long-Term Survival of Corneal Allografts Is Dependent on Intact CD1d-Reactive NKT Cells1 (2002) (89)
Suppressive and enhancing T-cell factors as I-region gene products: properties and the subregion assignment. (1977) (89)
Regulation of homocytotropic antibody formation in the rat. 8. An antigen-specific T cell factor that regulates anti-hapten homocytotropic antibody response. (1973) (89)
PDC-TREM, a plasmacytoid dendritic cell-specific receptor, is responsible for augmented production of type I interferon (2008) (89)
Ultraviolet A-induced Production of Matrix Metalloproteinase-1 Is Mediated by Macrophage Migration Inhibitory Factor (MIF) in Human Dermal Fibroblasts* (2004) (87)
Functional and molecular organisation of an antigen-specific suppressor factor from a T-cell hybridoma (1980) (86)
alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. (2000) (86)
Construction of an open-access database that integrates cross-reference information from the transcriptome and proteome of immune cells (2007) (84)
Positive selection of invariant V alpha 14+ T cells by non-major histocompatibility complex-encoded class I-like molecules expressed on bone marrow-derived cells. (1995) (84)
The roles of intrahepatic Vα14+ NK1.1+ T cells for liver injury induced by Salmonella infection in mice (1999) (83)
Role of interferon-γ in Vα14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs (2007) (83)
Induction of Regulatory Properties in Dendritic Cells by Vα14 NKT Cells1 (2005) (82)
Recognition and function of Vα14 NKT cells (2000) (82)
A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. (1999) (80)
Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in 2-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis. (2011) (80)
Selective reduction and recovery of invariant Valpha24JalphaQ T cell receptor T cells in correlation with disease activity in patients with systemic lupus erythematosus. (2001) (78)
Natural killer T cell‐mediated antitumor immune responses and their clinical applications (2006) (76)
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. (1999) (75)
The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity‐associated immune deviation (2005) (75)
The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy. (2010) (75)
Activation of Natural Killer T Cells Ameliorates Postinfarct Cardiac Remodeling and Failure in Mice (2012) (74)
Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer. (2008) (74)
Single Dose of OOCH Improves Mucosal T Helper Type 1/T Helper Type 2 Cytokine Balance and Prevents Experimental Colitis in the Presence of V&agr;14 Natural Killer T Cells in Mice (2005) (73)
Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia (2000) (73)
Cutting Edge: Critical Role of CXCL16/CXCR6 in NKT Cell Trafficking in Allograft Tolerance 1 (2005) (73)
Presence of interchain disulfide bonds between two gene products that compose the secreted form of an antigen-specific suppressor factor (1981) (73)
A novel recognition motif of human NKT antigen receptor for a glycolipid ligand. (1999) (73)
Mycobacterial infection in natural killer T cell knockout mice. (2002) (70)
An Anti-Inflammatory Role for Vα14 NK T cells in Mycobacterium bovis Bacillus Calmette-Guérin-Infected Mice1 (2003) (70)
Host-Residual Invariant NK T Cells Attenuate Graft-versus-Host Immunity1 (2005) (70)
CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. (2003) (70)
Resistance of Natural Killer T Cell–Deficient Mice to Systemic Shwartzman Reaction (2000) (69)
Predominant expression of invariant V alpha 14+ TCR alpha chain in NK1.1+ T cell populations. (1995) (68)
Inhibition of tumor metastasis by adoptive transfer of IL‐12‐activated Vα14 NKT cells (2001) (65)
Regulation of homocytotropic antibody formation in the rat. VII. Carrier functions in the anti-hapten homocytotropic antibody response. (1972) (65)
Induction of differentiation of pre-NKT cells to mature Valpha14 NKT cells by granulocyte/macrophage colony-stimulating factor. (1999) (64)
Occurrence of tumor-associated ganglioside antigens with Hanganutziu-Deicher antigenic activity on human melanomas. (1987) (64)
Interleukin (IL)-4-independent Maintenance of Histone Modification of the IL-4 Gene Loci in Memory Th2 Cells* (2004) (64)
Natural killer T-cells participate in rejection of islet allografts in the liver of mice. (2006) (63)
Involvement of decidual Valpha14 NKT cells in abortion. (2000) (62)
Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6. (2009) (62)
Regulation of T helper type 2 cell differentiation by murine Schnurri-2 (2005) (62)
Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma. (1985) (61)
Critical Role for CXC Chemokine Ligand 16 (SR-PSOX) in Th1 Response Mediated by NKT Cells1 (2007) (60)
Studies on passive serum sickness. II. Factors determining the localization of antigen-antibody complexes in the murine renal glomerulus. (1978) (59)
Accumulation of Activated Invariant Natural Killer T Cells in the Tumor Microenvironment after α-Galactosylceramide-Pulsed Antigen Presenting Cells (2012) (58)
Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells. (2010) (58)
Cellular consequences in the suppression of antibody response by the antigen-specific T-cell factor (1980) (57)
Mechanism of NKT Cell‐Mediated Transplant Tolerance (2007) (55)
Role of Vα 14 NKT cells in the development of impaired liver regeneration in vivo (2003) (55)
The importance of CD25+CD4+ regulatory T cells in mouse hepatic allograft tolerance (2006) (54)
Role of interferon-gamma in Valpha14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs. (2007) (53)
An antigen-specific I region gene product that augments the antibody response. (1978) (52)
Abundance of unconventional CD8+ natural killer T cells in the large intestine (2001) (52)
Syngeneic monoclonal antibodies against melanoma antigens with species specificity and interspecies cross-reactivity. (1984) (51)
Suppression of eosinophilic airway inflammation by treatment with α‐galactosylceramide (2005) (49)
Extrathymic Differentiation of a T Cell Bearing Invariant Vα14Jα281 TCR (1994) (48)
The Induced Regulatory T Cell Level, Defined as the Proportion of IL-10+Foxp3+ Cells among CD25+CD4+ Leukocytes, Is a Potential Therapeutic Biomarker for Sublingual Immunotherapy: A Preliminary Report (2010) (48)
Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide. (2006) (47)
Efficient Regeneration of Human Vα24+ Invariant Natural Killer T Cells and Their Anti‐Tumor Activity In Vivo (2016) (47)
CD1d and CD1d‐restricted iNKT‐cells play a pivotal role in contact hypersensitivity (2005) (46)
Alternative pathway for the development of Vα14+ NKT cells directly from CD4–CD8– thymocytes that bypasses the CD4+CD8+ stage (2017) (46)
Phenotypes and invariant alpha beta TCR expression of peripheral V alpha 14+ NK T cells. (1997) (46)
CD28 Costimulation Controls Histone Hyperacetylation of the Interleukin 5 Gene Locus in Developing Th2 Cells* (2004) (46)
Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus. (2008) (46)
Escape mechanisms of melanoma from immune system by soluble melanoma antigen. (1988) (45)
The Pten/PI3K pathway governs the homeostasis of Valpha14iNKT cells. (2007) (45)
Role of Valpha14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance. (2008) (45)
Minimal Contribution of Vα14 Natural Killer T Cells to Th1 Response and Host Resistance against Mycobacterial Infection in Mice (2002) (44)
Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to Vα14 NKT cells (2001) (43)
Reconstitution of antigen-specific suppressor activity with translation products of mRNA (1982) (43)
Expansion of NK Cells with Reduction of Their Inhibitory Ly-49A, Ly-49C, and Ly-49G2 Receptor-Expressing Subsets in a Murine Helminth Infection: Contribution to Parasite Control1 (2002) (43)
Plasma membrane‐focused proteomics: Dramatic changes in surface expression during the maturation of human dendritic cells (2005) (42)
Fc receptor beta subunit is required for full activation of mast cells through Fc receptor engagement. (1999) (42)
Regulatory dendritic cells protect against allergic airway inflammation in a murine asthmatic model. (2008) (42)
Suppression of mast cell degranulation by a novel ceramide kinase inhibitor, the F-12509A olefin isomer K1. (2005) (41)
RCAI-61, the 6′-O-methylated analog of KRN7000: its synthesis and potent bioactivity for mouse lymphocytes to produce interferon-γ in vivo (2008) (41)
CD2 can mediate TCR/CD3-independent T cell activation. (1991) (40)
Induction of regulatory properties in dendritic cells by Valpha14 NKT cells. (2005) (40)
Regulatory Role of Peritoneal NK1.1+αβ T Cells in IL-12 Production During Salmonella Infection (1999) (40)
TH1-biased immunity induced by exposure to Antarctic winter. (2003) (40)
Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells (2016) (40)
Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL‐18 (2003) (40)
Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice. (2013) (39)
Two distinct allotypic determinants on the antigen-specific suppressor and enhancing T cell factors that are encoded by genes linked to the immunoglobulin heavy chain locus (1982) (39)
STAT6-Dependent Differentiation and Production of IL-5 and IL-13 in Murine NK2 Cells1 (2004) (39)
Accumulation of somatic hypermutation and antigen‐driven selection in rapidly cycling surface Ig+ germinal center (GC) B cells which occupy GC at a high frequency during the primary antihapten response in mice (1997) (38)
Adjuvant activity mediated by iNKT cells. (2010) (38)
Cysteine-dependent immune regulation by TRX and MIF/GIF family proteins. (2004) (38)
Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice (2015) (38)
I–J as an idiotype of the recognition component of antigen-specific suppressor T-cell factor (1985) (37)
Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells. (2000) (37)
RCAI-8, 9, 18, 19, and 49-52, conformationally restricted analogues of KRN7000 with an azetidine or a pyrrolidine ring: Their synthesis and bioactivity for mouse natural killer T cells to produce cytokines. (2008) (37)
RCAI-56, a carbocyclic analogue of KRN7000: its synthesis and potent activity for natural killer (NK) T cells to preferentially produce interferon-γ (2007) (37)
Shared antigenic determinant expressed on various mammalian melanoma cells. (1984) (37)
Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients. (2002) (36)
Specific suppression of the immune response by a factor obtained from spleen cells of mice tolerant to human gamma-globulin. (1978) (36)
Successful Islet Transplantation to Two Recipients From a Single Donor by Targeting Proinflammatory Cytokines in Mice (2007) (36)
Regulation of homocytotropic antibody formation in the rat. X. IgT-like molecule for the induction of homocytotropic antibody response. (1972) (36)
Treatment with α-Galactosylceramide Attenuates the Development of Bleomycin-Induced Pulmonary Fibrosis (2004) (36)
Induction of negative signal through CD2 during antigen-specific T cell activation. (1991) (36)
Monoclonal antibodies that recognize the product controlled by a gene in the I-J subregion of the mouse H-2 complex (1981) (35)
Absence of the CD1 Molecule Up-Regulates Antitumor Activity Induced by CpG Oligodeoxynucleotides in Mice1 (2002) (35)
CHARACTERIZATION OF THE ANTIGEN-SPECIFIC SUPPRESSIVE T CELL FACTOR WITH SPECIAL REFERENCE TO THE EXPRESSION OF I REGION GENES (1976) (35)
A Phase I-II Study of -Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer (2009) (34)
KLRG+ invariant natural killer T cells are long-lived effectors (2014) (34)
Evaluation of the Function of Human Invariant NKT Cells from Cancer Patients Using α-Galactosylceramide-Loaded Murine Dendritic Cells1 (2006) (34)
Invariant NKT cells produce IL-17 through IL-23-dependent and -independent pathways with potential modulation of Th17 response in collagen-induced arthritis Corrigendum in /ijmm/31/4/998 (2008) (34)
NKT cells are relatively resistant to apoptosis. (2004) (34)
Generation of functional NKT cells in vitro from embryonic stem cells bearing rearranged invariant Valpha14-Jalpha18 TCRalpha gene. (2010) (33)
B cell precursors are present in the thymus during early development (1989) (33)
Synthesis and biological activity of ester and ether analogues of alpha-galactosylceramide (KRN7000). (2010) (33)
Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells. (2010) (33)
Impaired Ca/calcineurin pathway in in vivo anergized CD4 T cells. (2000) (32)
Expansion of Lung Vα14 NKT Cells by Administration of α‐Galactosylceramide‐pulsed Dendritic Cells (2002) (32)
TCR Vα14+ natural killer T cells function as effector T cells in mice with collagen‐induced arthritis (2005) (32)
DUAL REGULATORY ROLE OF THE THYMUS IN THE MATURATION OF IMMUNE RESPONSE IN THE RABBIT (1974) (31)
Decreased TCR AV24AJ18+ double-negative T cells in rheumatoid synovium. (1999) (31)
Impaired contact hypersensitivity in macrophage migration inhibitory factor‐deficient mice (2003) (31)
Recognition and function of Valpha14 NKT cells. (2000) (31)
Injury-Induced Suppression of Effector T Cell Immunity Requires CD1d-Positive APCs and CD1d-Restricted NKT Cells1 (2006) (31)
Suppression of eosinophilic airway inflammation by treatment with alpha-galactosylceramide. (2005) (30)
Impaired IFN‐γ production of Vα24 NKT cells in non‐remitting sarcoidosis (2004) (30)
Immunoregulatory role of Jα281 T cells in aged mice developing lupus‐like nephritis (2007) (30)
Human NK cell development in hIL-7 and hIL-15 knockin NOD/SCID/IL2rgKO mice (2019) (30)
DOCK2 Is Required in T Cell Precursors for Development of Vα14 NK T Cells1 (2006) (30)
Functional roles of NKT cell in the immune system. (2004) (30)
SHIP Influences Signals from CD48 and MHC Class I Ligands That Regulate NK Cell Homeostasis, Effector Function, and Repertoire Formation (2010) (28)
Dendritic cell maturation by CD11c− T cells and Vα24+ natural killer T‐cell activation by α‐Galactosylceramide (2005) (28)
[The regulatory role of V alpha 14 NKT cells in innate and acquired immune response]. (2002) (28)
Protective Roles of B and T Lymphocyte Attenuator in NKT Cell-Mediated Experimental Hepatitis (2009) (28)
Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy (2015) (27)
Activation of pulmonary invariant NKT cells leads to exacerbation of acute lung injury caused by LPS through local production of IFN-γ and TNF-α by Gr-1+ monocytes. (2011) (27)
Invariant NKT Cells Are Essential for the Regulation of Hepatic CXCL10 Gene Expression during Leishmania donovani Infection (2005) (27)
An Anti-Inflammatory Role for V 14 NK T cells in Mycobacterium bovis Bacillus Calmette-Guérin-Infected Mice (2003) (26)
RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage: their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines. (2008) (26)
Ras Activation in T Cells Determines the Development of Antigen-Induced Airway Hyperresponsiveness and Eosinophilic Inflammation1 (2002) (26)
SUPPRESSIVE T CELL FACTOR AND ITS ACCEPTOR EXPRESSED ON DIFFERENT SUBSETS OF T CELLS: A POSSIBLE AMPLIFICATION LOOP IN THE SUPPRESSOR SYSTEM (1978) (26)
Monoclonal alloantibodies specific for the constant region of T cell antigen receptors (1982) (26)
CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4. (2006) (26)
Constant region determinants on the antigen-binding chain of the suppressor T-cell factor (1982) (26)
Mouse alloantibodies capable of blocking cytotoxic T cell function. III. Studies of the mechanism of blocking of CML by anti-Lyt-2 antibodies. (1981) (25)
Lymphoid enhancer factor interacts with GATA‐3 and controls its function in T helper type 2 cells (2008) (25)
Generation of Novel Traj18-Deficient Mice Lacking Vα14 Natural Killer T Cells with an Undisturbed T Cell Receptor α-Chain Repertoire (2016) (25)
Cytotoxic T lymphocytes induced by syngeneic mouse melanoma cells recognize human melanomas (1981) (25)
RCAI-37, 56, 59, 60, 92, 101, and 102, cyclitol and carbasugar analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines. (2009) (24)
Mouse Alloantibodies Capable of Blocking Cytotoxic T Cell Function (1983) (24)
Melanoma antigen expression and metastatic ability of mutant B16 melanoma clones (1988) (24)
DOCK2 is required in T cell precursors for development of Valpha14 NK T cells. (2006) (23)
Regulatory Roles of NKT Cells in the Induction and Maintenance of Cyclophosphamide-Induced Tolerance1 (2006) (23)
Potentiation of antitumor effect of NKT cell ligand, α-galactosylceramide by combination with IL-12 on lung metastasis of malignant melanoma cells1 (2004) (23)
Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of α‐galactosylceramide and interleukin‐18 (2007) (23)
Regulation of Toll-like receptor 4 expression in mouse colon by macrophage migration inhibitory factor (2006) (23)
A Novel Approach Inducing Transplant Tolerance by Activated Invariant Natural Killer T Cells With Costimulatory Blockade (2014) (22)
Vα14 NKT cell-mediated anti-tumor responses and their clinical application (2005) (22)
A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine (2005) (22)
Mesenchymal expression of Foxl1, a winged helix transcriptional factor, regulates generation and maintenance of gut-associated lymphoid organs. (2003) (22)
A new Pax gene, Pax-9, maps to mouse Chromosome 12 (2004) (22)
Invariant Vα14 Chain NKT Cells Promote Plasmodium berghei Circumsporozoite Protein-Specific Gamma Interferon- and Tumor Necrosis Factor Alpha-Producing CD8+ T Cells in the Liver after Poxvirus Vaccination of Mice (2005) (22)
Activation of natural killer T cells by α‐carba‐GalCer (RCAI‐56), a novel synthetic glycolipid ligand, suppresses murine collagen‐induced arthritis (2011) (21)
Synthesis and biological activity of hydroxylated analogues of KRN7000 (α-galactosylceramide). (2013) (21)
Human Th1 differentiation induced by lipoarabinomannan/lipomannan from Mycobacterium bovis BCG Tokyo-172. (2008) (21)
Involvement of CD1 in Peripheral Deletion of T Lymphocytes Is Independent of NK T Cells1 (2001) (21)
Natural Killer T Cell Ligand α‐Galactosylceramide Inhibited Lymph Node Metastasis of Highly Metastatic Melanoma Cells (1999) (21)
Distinct subcellular localization and substrate specificity of extracellular signal-regulated kinase in B cells upon stimulation with IgM and CD40. (1999) (21)
Regulation of early T cell development by the PHD finger of histone lysine methyltransferase ASH1. (2008) (20)
Activation of acceptor-suppressor hybridoma with antigen-specific suppressor T cell factor of two-chain type: requirement of the antigen- and the I-J-restricting specificity. (1984) (19)
Bone Marrow Allograft Rejection Mediated by a Novel Murine NK Receptor, NKG2I (2004) (19)
NKT cells play a limited role in the neutrophilic inflammatory responses and host defense to pulmonary infection with Pseudomonas aeruginosa. (2006) (19)
NKT cells turn ten (2009) (19)
Functional roles of two polypeptide chains that compose an antigen- specific suppressor T cell factor (1984) (19)
Treatment with alpha-galactosylceramide attenuates the development of bleomycin-induced pulmonary fibrosis. (2004) (19)
Limited T cell antigen receptor repertoire in tumor-infiltrating lymphocyte and inhibition of experimental lung metastasis of murine melanoma by anti-TCR antibody. (1995) (18)
Vα14+ NK T cells: A novel lymphoid cell lineage with regulatory function (1996) (18)
Extrathymic differentiation of a T cell bearing invariant V alpha 14J alpha 281 TCR. (1994) (18)
Distribution of a cross-species melanoma-associated antigen in normal and neoplastic human tissues. (1985) (18)
Impaired IFN-gamma production of Valpha24 NKT cells in non-remitting sarcoidosis. (2004) (18)
Anti‐tumor effect of internal image bearing anti‐idiotypic monoclonal antibody in relation to GM3 ganglioside (1998) (17)
Density of GM3 with Normal Primary Structure Determines Mouse Melanoma Antigenicity; a New Concept of Tumor Antigen (1989) (17)
RCAI-61 and related 6'-modified analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce interferon-γ in vivo. (2013) (17)
Identification of CD4−CD8− Double-Negative Natural Killer T Cell Precursors in the Thymus (2008) (17)
Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-γ produced in part by iNKT cells. (2014) (17)
Coexistence of variable region of immunoglobulin heavy chain and I region gene products on antigen-specific suppressor T cells and suppressor T cell factor. A minimal model of functional antigen receptor of T cells. (1980) (17)
A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver (2018) (16)
Distinct regulatory functions of SLP-76 and MIST in NK cell cytotoxicity and IFN-gamma production. (2008) (16)
Characterization of a human monoclonal antibody with broad reactivity to malignant tumor cells. (1988) (16)
Mouse melanoma antigen recognized by Lyt-2- and L3T4- cytotoxic T-lymphocytes. (1988) (16)
Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy (2016) (16)
Monoclonol antibody against murine T cell receptor Vα14 cross-reacts with human CD3θ and detects disulfide-linked dimeric form (1991) (15)
Development of hapten-induced IL-4-producing CD4+ T lymphocytes requires early IL-4 production by alphabeta T lymphocytes carrying invariant V(alpha)14 TCR alpha chains. (1998) (15)
Investigation of the role of CD1d-restricted invariant NKT cells in experimental choroidal neovascularization. (2008) (15)
Syngeneic monoclonal anti-melanoma antibody that inhibits experimental lung metastasis of B16 melanoma. (1986) (15)
Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys (2015) (15)
Pretreatment of Donor Islets With the Na+/Ca2+ Exchanger Inhibitor Improves the Efficiency of Islet Transplantation (2013) (15)
Functional maturation of lamina propria dendritic cells by activation of NKT cells mediates the abrogation of oral tolerance (2008) (15)
IL-4 and T Cells Are Required for the Generation of IgG1 Isotype Antibodies Against Cardiolipin1 (2002) (15)
MULTIPLE MHC LOCI CONTROLLING LYMPHOCYTE INTERACTIONS (1979) (15)
Double-step and inverse polymerase chain reaction for sensitive detection and cloning of T cell receptor variable region sequences. (1991) (14)
Chemical features of an antigen-specific suppressor T cell factor composed of two polypeptide chains. (1984) (14)
Natural Killer T Cell-Targeted Immunotherapy Mediating Long-term Memory Responses and Strong Antitumor Activity (2017) (14)
Spontaneous tolerance involving natural killer T cells after hepatic grafting in mice. (2007) (14)
Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy (2012) (14)
Change in the topographical distribution of GM3 during cell spreading and growth: immunostaining with monoclonal antibody against GM3. (1987) (14)
TCR AV24 gene expression in double negative T cells in systemic lupus erythematosus (1998) (14)
IL-4 and T Cells Are Required for the Generation of IgG1 Isotype Antibodies Against Cardiolipin (2002) (13)
TCR Valpha14 natural killer T cells function as effector T cells in mice with collagen-induced arthritis. (2005) (13)
Positive selection of NKT cells by CD1+, CD11c+ non‐lymphoid cells residing in the extrathymic organs (1999) (13)
Prevention of acute and chronic allograft rejection by a novel retinoic acid receptor-alpha-selective agonist. (2004) (13)
MONOCLONALITY OF B‐CELL LINEAGE IN PRIMARY PULMONARY LYMPHOMA DEMONSTRATED BY IMMUNOGLOBULIN HEAVY CHAIN GENE SEQUENCE ANALYSIS OF HISTOLOGICALLY NON‐DEFINITIVE TRANSBRONCHIAL BIOPSY SPECIMENS (1996) (13)
Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to V(alpha)14 NKT cells. (2001) (13)
Target cells for an immunosuppressive cytokine, glycosylation-inhibiting factor. (1999) (13)
Dendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramide. (2005) (13)
Intestinal intraepithelial lymphocytes preferentially repopulate the intestinal epithelium. (1993) (13)
Toll-like receptors 2 and 4 are differentially involved in Fas dependent apoptosis in Peyer’s patch and the liver at an early stage after bile duct ligation in mice (2005) (13)
High frequency of loss of human kappa light chain expression in mouse-human heterohybridomas. (1987) (13)
Regulatory role of peritoneal NK1.1+ alpha beta T cells in IL-12 production during Salmonella infection. (1999) (13)
Epitope-specific regulation. IV. In vitro studies with suppressor T cells induced by carrier/hapten-carrier immunization. (1984) (13)
RCAI-84, 91, and 105-108, ureido and thioureido analogs of KRN7000: their synthesis and bioactivity for mouse lymphocytes to produce Th1-biased cytokines. (2012) (13)
Palifermin Mediates Immunoregulatory Effects in Addition to its Cytoprotective Effects in Mice with Acute Graft-Versus-Host Disease (2008) (12)
Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor. (1995) (12)
Valpha14 NKT cell-mediated anti-tumor responses and their clinical application. (2005) (12)
The role of natural killer T cells in costimulation blockade‐based mixed chimerism (2010) (12)
Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator1 (2003) (11)
Involvement of the acyl chain of ceramide in carbohydrate recognition by an anti-glycolipid monoclonal antibody: the case of an anti-melanoma antibody, M2590, to GM3-ganglioside (2005) (11)
A set of genes associated with the interferon‐γ response of lung cancer patients undergoing α‐galactosylceramide‐pulsed dendritic cell therapy (2010) (11)
Prophylaxis of lipopolysaccharide‐induced shock by α‐galactosylceramide (2008) (11)
Graft‐versus‐host disease in recipients of grafts from natural killer T cell‐deficient (Jα281–/–) donors (2006) (11)
Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review (2012) (11)
Acceptor-suppressor T cell hybridoma with a receptor recognizing antigen-specific suppressor factor (1983) (11)
Expansion of murine T cells bearing a unique T cell receptor beta-chain in Friend virus-induced tumor in situ. (1992) (11)
Convenient plasmid vectors for construction of chimeric mouse/human antibodies (1989) (11)
Establishment of human monoclonal antibody recognizing a new tumor-associated antigen from a patient with small cell lung carcinoma. (1990) (10)
Paradoxically high resistance of natural killer T (NKT) cell-deficient mice to Legionella pneumophila: another aspect of NKT cells for modulation of host responses. (2008) (10)
Expression of recombination-activating gene in mature peripheral T cells in Peyer's patch. (2003) (10)
Role of a NK receptor, KLRE-1, in bone marrow allograft rejection: analysis with KLRE-1-deficient mice. (2004) (10)
Recognition of alloantigen by cytotoxic T cell precursors is independent of the function of Ia+ cells. (1985) (10)
loss of syngeneic transplanted islets (2005) (10)
T(h)1/T(h)2 cell differentiation of developing CD4 single-positive thymocytes. (2002) (10)
A Single Cell Analysis of TCR AV24AJ18+ DN T Cells (1999) (10)
CD4 memory T cells develop and acquire functional competence by sequential cognate interactions and stepwise gene regulation. (2016) (9)
Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis. (2016) (9)
Corrigendum to “Suppression of mast cell degranulation by a novel ceramide kinase inhibitor, the F-12509A olefin isomer K1” [Biochim. Biophys. Acta 1738 (2005) 82–90] (2007) (9)
Novel mechanisms of specific suppression of anti-hapten antibody response mediated by monoclonal anti-carrier antibody. (1985) (9)
Contrasting roles for Vα14+ natural killer T cells in a viral model for multiple sclerosis (2009) (9)
Hsa-mir-144-3p expression is increased in umbilical cord serum of infants with atopic dermatitis. (2019) (9)
T Cell Receptor Vβ Repertoires of Angioimmunoblastic Lymphadenopathy-like T Cell Lymphoma (1994) (9)
Gamma Interferon Production by Hepatic NK T Cells during Escherichia coli Infection Is Resistant to the Inhibitory Effects of Oxidative Stress (2003) (9)
Anti-tumor effects of radiolabeled syngeneic monoclonal anti-melanoma antibodies. (1984) (9)
Extrathymic Development of Vα11 T Cells in Placenta During Pregnancy and Their Possible Physiological Role (2001) (8)
Autoreactive T-cell clones which suppress cytotoxic T cell responses. (1991) (8)
Characterization of a melanoma antigen with a mouse-specific epitope recognized by a monoclonal antibody with antimetastatic ability. (1988) (8)
Activation of murine invariant NKT cells promotes susceptibility to candidiasis by IL‐10 induced modulation of phagocyte antifungal activity (2016) (8)
Induction of Mouse Anti‐melanoma Cytotoxic and Suppressor T Cells in vitro by an Artificial Antigen, GM3‐lactone (1990) (7)
A limited role of iNKT cells in controlling systemic Candida albicans infections. (2012) (7)
Reactivity of mouse monoclonal antibody M2590 against B16 melanoma cells with chemically synthesized GM3 ganglioside. (1986) (7)
Ia ANTIGENS ON SUPPRESSOR, AMPLIFIER AND HELPER T CELLS (1979) (7)
RCAI-39, 41, 53, 100, 127 and 128, the analogues of KRN7000, activate mouse natural killer T cells to produce Th2-biased cytokines by their administration as liposomal particles (2011) (6)
Generation of induced pluripotent stem cell-derived mice by reprogramming of a mature NKT cell (2014) (6)
V alpha 14+ NK T cells: a novel lymphoid cell lineage with regulatory function. (1996) (6)
Third complementarity determining region sequence analysis of low-grade bronchus-associated lymphoid tissue lymphoma: genotypic analysis reveals heterogeneity in maturation. (1996) (6)
Establishment of internal-image anti-idiotype monoclonal antibodies to a human antibody to lung cancer (1997) (6)
Restricted Vβ gene usage of tumour-infiltrating T lymphocytes in primary gastric malignant B-cell lymphoma (2004) (6)
Development of hapten-induced IL-4-producing CD 4 F T lymphocytes requires early IL-4 production by αβ T lymphocytes carrying invariant V α 14 TCR α chains (1998) (6)
Transduction of effector-suppressor T cells by an antigen-specific suppressor T cell factor and Lyt-1+,2+,3+ T cells. (1984) (5)
Sandwich radioimmunoassay using single monoclonal antibody that detects minute amounts of melanoma antigens from various mammalian species. (1984) (5)
Antigen-specific suppressive and enhancing T-cell factors determined by distinct loci in the I region of H-2 complex☆☆☆ (1976) (5)
Possible involvement of Ly-1 B cells in the effector phase of IgG suppression mediated by suppressor T cell factor. (1987) (5)
The Transcriptional Repressor Gfi1 Plays a Critical Role in the Development of NKT1- and NKT2-Type iNKT Cells (2016) (5)
Specific suppressor T cell hybridomas. (1978) (5)
“I‐J” as an Idiotypic Marker on the Antigen‐Specific Suppressor T Cell Factor (1985) (5)
The role of receptors for T cell products in antibody formation. (1976) (5)
Stimulation In Vitro and In Vivo NK Cell-Associated Molecules Upon T Cells Rapidly Acquire NK 1 . 1 and + CD 8 (2000) (4)
CD 4 1 CD 25 1 T-cell development is regulated by at least 2 distinct mechanisms (2001) (4)
Restricted V beta gene usage of tumour-infiltrating T lymphocytes in primary gastric malignant B-cell lymphoma. (1995) (4)
Expression of IgH promoter/enhancer Ly-1 transgene in hematopoietic chimeric mice generated by embryonic stem cell line. (1990) (4)
A MINIMAL MODEL OF T CELL-MEDIATED REGULATION OF THE ANTIBODY RESPONSE (1980) (4)
Breastfeeding promotes egg white sensitization in early infancy (2020) (4)
Monoclonal antibody against murine T cell receptor V alpha 14 cross-reacts with human CD3 epsilon and detects disulfide-linked dimeric form. (1991) (4)
THE ESTABLISHMENT OF T CELL HYBRIDOMAS WITH SPECIFIC SUPPRESSIVE FUNCTION (1979) (3)
Suppressor T cells belong to the self-reactive repertoire. (1989) (3)
Syngeneic monoclonal antimelanoma antibodies and their application for analysis of tumor antigens, gene cloning, and in vitro/in vivo diagnosis. (1989) (3)
Pillars article: homogenous junctional sequence of the V14+ T-cell antigen receptor α chain expanded in unprimed mice. Proc. Natl. Acad. Sci. U.S.A. 1990. 87: 5248-5252. (2014) (3)
Heterogeneity of I-J Subregion Gene Products: Their Expression on Functionally Different Subsets of T Cells (1978) (3)
Properties of Mouse Melanoma Antigen and Its Secretion Mechanism from the Cell Surface (1989) (3)
Regulation of the antibody response by T cell-derived factors: their heterogeneity and genetics. (1979) (3)
THE ABILITY OF INTERSPECIES CROSSREACTIVE ANTI‐Ia MURINE ALLOANTIBODIES TO ELIMINATE A SUBPOPULATION OF HUMAN ADHERENT CELLS RESPONSIBLE FOR INDUCTION OF ALLOIMMUNITY (1983) (3)
Acquisition of repertoires of suppressor T cells under the influence of macrophages. (1988) (3)
Production of Monoclonal Anti-Basic Fetoprotein (BFP) and Usefulness of Monoclonal Anti-BFP for Immunodiagnosis of Human Cancer (1983) (3)
Synthesis of RCAI-172 (C6 epimer of RCAI-147) and its biological activity. (2014) (2)
Murine induced pluripotent stem cells can be derived from and differentiate into natural killer T cells (2010) (2)
Specific biodetection of B16 mouse melanoma in vivo by syngeneic monoclonal antibody. (1987) (2)
Detection of antigen-specific suppressor T cell factor by sandwich radioimmunoassay using two monoclonal antibodies with different specificities. (1985) (2)
Antigen-specific suppressor T cells and their soluble products. (1985) (2)
Isolation of Genomic DNA Controlling Mouse Melanoma Antigen Defined by Monoclonal Antibody (1988) (2)
Prolongation of Rat Islet Xenograft Survival in the Liver of IFN-γ-Deficient Mice (2000) (2)
Antigen-specific and nonspecific suppressor factors derived from T cell hybridomas: their function and molecular organization. (1981) (2)
HIV-1 Nef impairs multiple T-cell functions in antigen-specific immune response in mice. (2011) (2)
TCR repertoire in early fetal mouse thymus. (1995) (2)
Advances in Brief Antitumor Cytotoxicity Mediated by Ligand-activated Human V a 24 NKT Cells 1 (1999) (2)
Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors. (2006) (2)
Dependent on Intact CD 1 d-Reactive NKT Long-Term Survival of Corneal Allografts (2002) (2)
Oligodeoxynucleotides in Mice Antitumor Activity Induced by CpG Absence of the CD1 Molecule Up-Regulates (2002) (2)
The Role of α-Galactosylceramide-Activated Vα14 Natural Killer T Cells in the Regulation of Th2 Cell Differentiation (2001) (2)
Invariant Natural Killer T Cells Play a Role in Chemotaxis, Complement Activation and Mucus Production in a Mouse Model of Airway Hyperreactivity and Inflammation (2015) (2)
Evolution of Vα14 TCR Gene Family in Mice (1994) (2)
T cell receptor V beta repertoires of angioimmunoblastic lymphadenopathy-like T cell lymphoma. (1994) (2)
Molecular analysis of suppressor T cell receptors. (1988) (2)
Immunomodulatory Cell Therapy Using αGalCer-Pulsed Dendritic Cells Ameliorates Heart Failure in a Murine Dilated Cardiomyopathy Model (2022) (1)
The Analysis of Immature Lymphoid Precursors Stored in Longterm Bone Marrow Culture (1988) (1)
Introduction: Mechanisms of NKT-Cell-Mediated Adjuvant Activity and Function of iPS-Derived NKT Cells (2012) (1)
An antigen-specific suppressor T cell factor controlled by two genes in the immunoglobulin heavy chain linkage group and in the I-J subregion of the H-2 complex. (1982) (1)
The use of a monoclonal I-J-specific antibody to distinguish cells in the feedback suppression circuit from those in the contrasuppressor circuit (2004) (1)
NKT cells regulate the development of asthma (2005) (1)
[V alpha 14 NKT cells as a novel immune system]. (1999) (1)
The role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of Th2 cell differentiation. (2001) (1)
The protective function of invariant natural killer T cells in the relapse of experimental autoimmune uveoretinitis. (2020) (1)
Pneumocystis Carinii Pneumonia in Japan, Especially in Infancy and Childhood (Report of Two Autopsied Cases and Review of Literature) (1974) (1)
OCH, a newly synthetic glycolipid, enhances protective immunity against mouse DSS-induced colitis in the presence of Vα14 natural killer T cells (2003) (1)
Prolongation of rat islet xenograft survival in the liver of IFN-gamma-deficient mice. (2000) (1)
Synthesis and biological activity of hydroxylated analogs of RCAI-80 (2013) (1)
Method of Genomic DNA Cloning by the Combination of Cosmid Shuttle Vector and Monoclonal Antibody (1988) (1)
Generation of functional NKT cells in vitro from embryonic stem cells bearing rearranged invariant V (cid:1) 14-J (cid:1) 18 TCR (cid:1) gene (2009) (1)
[GM3 ganglioside as melanoma specific antigen and its biological function]. (1989) (1)
RCAI-133, an N-methylated analogue of KRN7000, activates mouse natural killer T cells to produce Th2-biased cytokines (2013) (1)
NKT Cells and Their Recognition of Glycolipids (2008) (1)
Application of NKT Cells in Immunotherapy (2010) (1)
Protective role for CD1d-reactive invariant natural killer T cells in cauterization-induced corneal inflammation. (2008) (1)
Human Monoclonal Antibody Detects a Cell Surface Antigen Expressed on Hematopoietic Malignant Cells of Lymphoid Lineage (1991) (1)
[A novel immune system]. (1997) (1)
Cross-Species Melanoma Antigen (1990) (0)
Association of the (1995) (0)
Abstract 039: Natural Killer T Cells Play Protective Roles in Cardiovirus-Induced Myocarditis by Inducing Anti-Viral and Regulatory Cytokines (2013) (0)
Contents, Vol. 99, 1992 (1992) (0)
Contents, Vol. 66, Supplement 1, 1981 (1981) (0)
THE SITE OF ACTION OF IMMUNOSUPPRESSIVE AGENTS IN THE PRIMARY ANTIBODY RESPONSE OF THE RAT WITH SPECIAL REFERENCE TO IgE ANTIBODY FORMATION (1974) (0)
Suppressor T-Cell Hybridoma with a Receptor Recognizing KLH-Specific Suppressor Factor (1984) (0)
Molecular Cloning of Genomic DNA Controlling Expression of Mouse Melanoma Antigen and Transforming Activity (1987) (0)
CD1d/NKT cells (PP-006) (2010) (0)
Production of IL-5 and IL-13 in Murine NK 2 STAT 6-Dependent Differentiation and Taniguchi and Toshinori (2004) (0)
A NOVEL IMMUNE SYSTEM: Vα 14 NKT CELLS (1999) (0)
IMPORTANCE OF NATURAL KILLER T CELLS EXPRESSING CD4 FOR ACCEPTANCE OF INTRAHEPATIC RAT ISLET XENOGRAFTS IN MICE TREATED WITH ANTI-CD4 MONOCLONAL ANTIBODY (1998) (0)
CellsT Lymphocytes Is Independent of NK T Involvement of CD 1 in Peripheral Deletion of and (2001) (0)
Soluble T cell receptors alpha chains and derivatives thereof used as a prophylactic and therapeutic agent against autoimmune diseases (1994) (0)
Model and Dose Dependent Mechanisms of Innate Immunity That Are The Anti-Tumor Activity of IL-12: (2000) (0)
A phase I/II study of {alpha}Galactosylceramide-pulsed dendritic cells in patients with advanced or recurrent non-small cell lung cancer (2008) (0)
Peyer's patch and liver at an early stage after bile duct ligation in mice Short title: Roles of TLRs in pathogenesis of cholestasis (2005) (0)
Contents Vol. 153, 2010 (2010) (0)
Generation of TRAF5 deficient mice by gene targeting. (1998) (0)
Invariant V (cid:2) 14 Chain NKT Cells Promote Plasmodium berghei Circumsporozoite Protein-Speciﬁc Gamma Interferon- and Tumor Necrosis Factor Alpha-Producing CD8 (cid:1) T Cells in the Liver after Poxvirus Vaccination of Mice (2005) (0)
Use of a-Glycosylceramiden for producing a therapeutic agent for the treatment of autoimmune diseases (1998) (0)
MASARU TANIGUCHI AND TOMIO TADA 125 body synthesis . II . Effect of antigen dose and suppression by passive antibody on the affinity of antibody synthesized (2003) (0)
Using a-glycosylceramides for obtaining a therapeutic agent for autoimmune diseases. (1998) (0)
A Role for Natural Killer T‐Cell Subsets in the Pathogenesis of Various Allergic Disorders (2011) (0)
NKT Cells ProTh 2 Effect of IL-18 Exerted Through Ligand-Activated NKT Lymphocytes : A IL-18 Enhances IL-4 Production (2000) (0)
Marrow: Divergence from the Thymus Heterogeneity of NK1.1+ T Cells in the Bone (2013) (0)
Differential roles of NK and NK-T cells for regulation of EAE (1998) (0)
ESSENTIAL ROLES OF V &agr; 14 NKT CELLS FOR ACCEPTANCE OF RAT ISLET XENOGRAFTS IN MICE TREATED WITH ANTICD4 MONOCLONAL ANTIBODY.: Abstract# 125 (2000) (0)
Efficient regeneration of Human Vα24(+) invariant NKT cells and their anti-tumor activity in vivo. (2016) (0)
[Mouse melanoma antigen immunological properties, structure and genes]. (1986) (0)
Correction (2004) (0)
[A novel immune system: V alpha 14 NKT cells]. (1999) (0)
New pseudoglucolípido and use thereof (2008) (0)
Application and Limitations of Differential Hybridization in the Isolation of T Cell‐Specific cDNA Clones (1987) (0)
Dendritic cells: function (PP-024) (2010) (0)
[Biochemistry of melanoma-associated ganglioside antigens]. (1986) (0)
[Mouse melanoma antigen. Its immunological properties, partial structure and genes]. (1986) (0)
P-68 Synthesis of RCAI-56, a New Glycosphingolipid which Activates Natural Killer (NK) T Cells Effectively and Induces Preferential Production of Interferon-γ (2007) (0)
[Induction of allergic responses mediated by invariant iNKT]. (2012) (0)
CRUCIAL ROLE OF CD44 IN LIVER INFLAMMATION (2007) (0)
Acute murine graft-vs.-host disease (GVHD) induced using NKT cell knockout (Jα281−⧸−) donors (2005) (0)
Regulation of Toll-like receptor 4 expression in mouse colon by macrophage migration inhibitory factor (2005) (0)
Human monoclonal antibody to lung carcinoma and hybridoma producing the same (1989) (0)
Accumulation of Activated Invariant Natural Killer T Cells in the Tumor Microenvironment after α-Galactosylceramide-Pulsed Antigen Presenting Cells (2012) (0)
Implantation in Mice NK Cell-Dependent Resistance to Tumor-Galactosylceramide Induce Innate NKT and α Tumor Cells (2007) (0)
CD1d/NKT cells (WS-006) Chairpersons: Ken-ichiro Seino, Dale Godfrey (2010) (0)
Use of a-Glycosylceramiden for the preparation of a therapeutic treatment of autoimmune diseases Mittelszur (1998) (0)
Suppression of IgE antibody responses by NKT cells—mechanisms of NKT cell-mediated regulatory function (2005) (0)
4.02 – Innate Immunity: NKT Cells (2007) (0)
contain NKT cells activators Alpha glycosylceramides (1998) (0)
SL1 IL-21-induced IgE-B cell specific apoptosis mediated by NKT cells (2006) (0)
DETERMINATION AND CHARACTERIZATION OF MELANOMA ANTIGENS RECOGNIZED BY MONOCLONAL ANTIBODIES (1989) (0)
160 Candidate for Response Monitoring or Prognostic Biomarkers in Two-Year Sublingual Immunotherapy for Japanese Cedar Pollinosis (2012) (0)
[The novel immune system: V alpha 14NKT cells]. (1999) (0)
Experimental Hepatitis Attenuator in NKT Cell-Mediated Protective Roles of B and T Lymphocyte (2009) (0)
Rearrangement and transcription of a T-cell receptor , 8-chain gene in different T-cell subsets ( gene expression ) (0)
Suppressor T Cell Receptor and Functional Molecule (1987) (0)
Abstract 424: Chemokine CXCL14 is a multistep tumor suppressor (2015) (0)
Is there a Unique Language in the Immunoregulatory System (1988) (0)
Whole body irradiation induces IFN-gamma production in BALB/c mice by preventing the appearance of a V alpha 14(+)NK T downregulatory population. (2000) (0)
V-Alpha-14 T-Cell Antigen Receptor Repertoire and Its Function. (1992) (0)
[A specific ligand of V alpha 14 NKT cells and its presentation]. (2003) (0)
RCAI-56 (Ia), a Carbocyclic Analogue of KRN7000 (Ib): Its Synthesis and Potent Activity for Natural Killer (NK) T Cells to Preferentially Produce Interferon-γ. (2007) (0)
Melanoma Antigen and Transforming Gene (1988) (0)
Attenuate Graft-versus-Host Immunity Host-Residual Invariant NK T Cells (2005) (0)
A Novel Approach Inducing Transplant Tolerance by Activated Invariant Natural Killer T Cells with Co-stimulatory Blockade Authors (2014) (0)
Melanoma diagnosis means with contentfresh monoklonem specific antibodies (1983) (0)
[Monoclonal antitumor antibodies--its application to diagnosis and treatment of tumors]. (1983) (0)
Allograft Tolerance CXCL16/CXCR6 in NKT Cell Trafficking in Cutting Edge: Critical Role of (2005) (0)
NKCD 1 d-Dependent and CD 1 d-Independent Tissue-Specific Segregation of Taniguchi (1999) (0)
Subject Index Vol. 153, 2010 (2010) (0)
NKT Cells ( SR-PSOX ) in Th 1 Response Mediated by Critical Role for CXC Chemokine Ligand 16 (2007) (0)
Abstract 1541: NK cells are indispensable for suppression of tumor growth and metastasis in transgenic mice overexpressing chemokine CXCL14/BRAK (2012) (0)
Hematopoietic stem cells (+iPS) (WS-010) Chairpersons: Hiromitsu Nakauchi, Haruhiko Koseki (2010) (0)
Biochemical characterization of an antigen-specific suppressor T cell factor. (1989) (0)
Bleomycin-Induced Pulmonary Fibrosis Attenuates the Development of-Galactosylceramide α Treatment with Sekizawa (2004) (0)
Subject Index Vol. 144, 2007 (2007) (0)
Detection of clonal B cell populations in paraffin-embedded tissues of primary gastric and thyroidal B-cell lymphoma using the polymerase chain reaction. (1994) (0)
[Recognition of CD1d/glycolipid antigen complex by NKT cells and mechanisms in immune regulation]. (2008) (0)
Immunity Requires CD 1 d-Positive Injury-Induced Suppression of Effector T Faunce (2006) (0)
Contents Vol. 144, 2007 (2007) (0)
Selective Reduct ion o f T Cells Bearing InvariantVcx 24 Jc ~ Q Antigen Receptor in Patients with Systemic Sclerosis (2003) (0)
INDUCTION OF ALLERGIC RESPONSES MEDIATED BY INVARIANT NKT CELLS (2012) (0)
[Immunological analysis of melanoma specific antigen. II. Inhibition of killer T cell activity by anti-melanoma antibody and anti-H-2b antibody]. (1984) (0)
[Immunoregulation by suppressor T cells: discovery of a new immunoregulatory system through internal imaging]. (1987) (0)
[Immunological analysis of melanoma specific antigen. (I). In-vitro induction of melanoma-antigen specific killer T lymphocytes in primary immune response]. (1983) (0)
[Mouse monoclonal antibodies recognizing melanoma-associated ganglioside antigens]. (1985) (0)
Repertoire Formation Homeostasis , Effector Function , and CellMHC Class I Ligands That Regulate NK SHIP Influences Signals from CD 48 and (2010) (0)
THEREGULATORYROLE OFVα14 NKT CELLS ININNATE ANDACQUIREDIMMUNERESPONSE (2003) (0)
Against Cardiolipin Generation of IgG 1 Isotype Antibodies IL-4 and T Cells Are Required for the (2002) (0)
CRUCIAL ROLE OF CD44 IN LIVER INFLAMMATION (97.6) (2007) (0)
Regulatory Cells in Systemic Tolerance Differentiation of Antigen-Specific T NK T Cell-Derived IL-10 Is Essential for the (2000) (0)
A phase I/II study of αGalactosylceramide-pulsed dendritic cells in patients with advanced or recurrent non-small cell lung cancer (2008) (0)
AN ANTIGEN-SPECIFIC SUPPRESSOR T CELL FACTOR COMPOSED OF TWO DISTINCT POLYPEPTIDE CHAINS (1983) (0)
Drug with regulatory cell ligand contained in the liposome (2005) (0)
Targeted disruption of dermatopontin leads to abnormal collagen fibrillogenesis. (2001) (0)
Acceptance of Murine Islet Allografts Without Immunosuppression in the Inguinal Subcutaneous White Adipose Tissue Pretreated with bFGF. (2022) (0)
Cyclophosphamide-Induced Tolerance Induction and Maintenance of Regulatory Roles of NKT Cells in the Yasui Yoshikai (2006) (0)
ACCEPTOR-SUPPRES SOR T CELL HYBRIDOMA WITH A RECEPTOR RECOGNIZING ANTIGEN-SPECIFIC (1983) (0)
Cell therapy (DC, Treg, NKT) (WS-040) Chairpersons: Toshinori Nakayama, Jay Berzofsky (2010) (0)
Extrathymic Development of Vcd 4-positive T Cells (2003) (0)
and CD1d-Restricted NKT Cells APCs Cell Immunity Requires CD1d-Positive Injury-Induced Suppression of Effector T (2013) (0)
Murine Helminth Infection: Contribution to Ly-49G2 Receptor-Expressing Subsets in a Their Inhibitory Ly-49A, Ly-49C, and Expansion of NK Cells with Reduction of (2013) (0)
A murine model of NKT cell-mediated liver injury induced by alpha-galactosylceramide/d-galactosamine (2006) (0)
WHOLE BODY IRRADIATION INDUCES IFN-γ PRODUCTION IN BALB/c MICE BY PREVENTING THE APPEARANCE OF A Vα14+NK T DOWNREGULATORY POPULATION (2000) (0)
Purification of T Cells from Spleen Cells by a Nylon Wool Column (2003) (0)
Cell therapy (SY5-1) Chairpersons: Masaru Taniguchi, Jacques Banchereau (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Masaru Chiba-shi Taniguchi?

Masaru Chiba-shi Taniguchi is affiliated with the following schools: